- Home
- ORGO vs BHK Comparison
ORGO vs BHK Comparison
Compare ORGO & BHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- BHK
- Stock Information
- Founded
- ORGO 1985
- BHK 2001
- Country
- ORGO United States
- BHK United States
- Employees
- ORGO N/A
- BHK N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- BHK Finance Companies
- Sector
- ORGO Health Care
- BHK Finance
- Exchange
- ORGO Nasdaq
- BHK Nasdaq
- Market Cap
- ORGO 665.8M
- BHK 539.0M
- IPO Year
- ORGO N/A
- BHK N/A
- Fundamental
- Price
- ORGO $4.45
- BHK $10.22
- Analyst Decision
- ORGO Buy
- BHK
- Analyst Count
- ORGO 2
- BHK 0
- Target Price
- ORGO $5.50
- BHK N/A
- AVG Volume (30 Days)
- ORGO 1.4M
- BHK 188.3K
- Earning Date
- ORGO 05-08-2025
- BHK 01-01-0001
- Dividend Yield
- ORGO N/A
- BHK 8.34%
- EPS Growth
- ORGO N/A
- BHK N/A
- EPS
- ORGO N/A
- BHK 1.03
- Revenue
- ORGO $482,043,000.00
- BHK N/A
- Revenue This Year
- ORGO $3.31
- BHK N/A
- Revenue Next Year
- ORGO $12.50
- BHK N/A
- P/E Ratio
- ORGO N/A
- BHK $10.42
- Revenue Growth
- ORGO 11.29
- BHK N/A
- 52 Week Low
- ORGO $2.17
- BHK $9.02
- 52 Week High
- ORGO $6.71
- BHK $11.09
- Technical
- Relative Strength Index (RSI)
- ORGO 52.57
- BHK 44.24
- Support Level
- ORGO $4.11
- BHK $9.95
- Resistance Level
- ORGO $4.38
- BHK $10.34
- Average True Range (ATR)
- ORGO 0.35
- BHK 0.25
- MACD
- ORGO 0.03
- BHK -0.02
- Stochastic Oscillator
- ORGO 80.17
- BHK 35.54
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About BHK Blackrock Core Bond Trust
Blackrock Core Bond Trust is a closed-ended management investment company. Its objective is to provide current income and capital appreciation. The trust seeks to achieve its investment objective by investing a majority of its managed assets in bonds that are investment-grade quality at the time of investment. The trust's investments will include a broad range of bonds, including corporate bonds, U.S. government and agency securities and mortgage-related securities.